First Import Analysis and the Release Letter

1. Key takeaways

Nicaragua places a quality-control gate on newly registered products after registration and before sale: on first import, an application for quality analysis must be filed with the Quality Control Laboratory Directorate within 15 working days of customs clearance (Note 1 of Article 14 of Annex I of RA 0007/2025), and the goods remain held until the results are issued. If the analysis is passed, the first-import release letter is issued within a maximum of 3 working days. If it fails, a new batch may be imported for re-testing within a maximum of 90 days, and the product may be replaced up to a third batch; failure at the third batch leads to cancellation of the registration. A failed batch must be destroyed within 20 working days under the supervision of ANRS representatives, at the importer’s expense.

2. Legal basis

The first-import gate rests on Article 8 of Chapter 7 of the technical standard and on Article 14 of Annex I, which supplies the deadlines. The key provisions are set out below.

3. Expert insights

Insight 1: the application window for the first-import quality check runs from the clearance date, not from the certificate issuance date. Note 1 of Article 14 of Annex I says «posterior a la nacionalización del producto» — after nationalization of the product. This differs from the renewal situation: sampling after renewal is described in Note 1 of Article 15 of Annex I as «posterior a la emisión de la renovación del registro» — 15 working days after issuance of the renewal — and where there is no stock on the market at the time of renewal, this may be extended to 15 working days from customs clearance of the import following renewal (Note 2). The two starting points belong to two different procedures and cannot be mixed.

Insight 2: the number of replacement opportunities is three, not two. Checking the text of Article 14 of Annex I in this volume: item 5 provides that if the first batch fails and a new analysis is not requested within 90 days, the registration is automatically cancelled; item 6 provides that if the second batch also fails, a new batch analysis may be requested again within 90 days; item 7 provides that if the third batch also fails, the registration is cancelled and the entire procedure must be restarted. In other words, the company effectively has three testing opportunities.

Insight 3: the release document has a different name for first import and for renewal. Item 8 of Article 14 issues the «carta de Autorización de Primera Importación»; item 7 of Article 15 issues the «carta de Autorización de Comercialización». Both are issued within a maximum of 3 working days, but they apply in different situations and carry different names, and should not be used interchangeably when filing.

Insight 4: the destruction obligation falls on the importer and comes with supervision. Note 3 reads «debiendo el importador asumir los gastos correspondientes de dicha destrucción en un plazo máximo de 20 días hábiles luego de notificada la no conformidad, con supervisión de delegados del ANRS» — the importer must bear the costs of destruction within a maximum of 20 working days after notification of non-compliance, under the supervision of ANRS delegates. The cost falls on the importer, the 20 working days run from notification of non-compliance, and the destruction must be supervised by ANRS representatives rather than handled by the importer alone.

Insight 5: sampling takes place within the premises of the establishment. Item 3 of Article 14 says «se presentarán a las instalaciones del establecimiento a realizar el retiro de las muestras» — they attend the premises of the establishment to withdraw the samples. The goods must therefore have cleared customs and entered the declarant’s premises before sampling can occur, which is why the first-import batch must complete customs clearance first.

Insight 6: the scope of products subject to testing is defined by an external document. Item 1 of Article 14 refers to RA 0029/2024, the «Guía del programa de vigilancia de mercado para el seguimiento de la calidad de productos médicos». This volume has not obtained the full text of that document and therefore does not presume which products must be tested and which are exempt; that determination should follow the official text and the DDM’s current practice.

4. Practical recommendations

• Run the 15-working-day clock from the customs clearance date, file the quality-analysis application within it, and notify the DDM of the arrival of the goods at the same time.
• Plan the first-import batch around three testing opportunities: do not abandon the product after a first failure, but arrange a second batch within 90 days; a third attempt remains if the second also fails.
• Pay at the current RM 347-2023 rate before re-testing a replacement batch, and submit the payment receipt with the application.
• Arrange destruction of failed batches against the three requirements — 20 working days, supervision by ANRS representatives and cost borne by the importer — and keep destruction records.
• Distinguish the first-import release letter from the post-renewal release letter when filing, since the names and the situations differ.
• Confirm in writing with the DDM whether the product falls within the testing scope defined by RA 0029/2024, rather than presuming an exemption.

5. Verification checklist

• □ Filed the quality-analysis application within 15 working days counted from the customs clearance date
• □ Notified the DDM of the arrival of the goods when they arrived (Chapter 7, Article 8)
• □ Planned the first-import batch around three testing opportunities and arranged a replacement batch within 90 days where needed
• □ Paid at the current RM 347-2023 rate before re-testing a replacement batch and obtained the receipt
• □ Arranged destruction of failed batches against the requirements of 20 working days, ANRS supervision and importer-borne cost
• □ Confirmed in writing with the DDM whether the product falls within the testing scope of RA 0029/2024

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com